Back to search
FDAFDA · Food and drugs·Recall number D-1127-2017

Famotidine for Oral Suspension USP, 40 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA, NDC 68180-150-01

Published September 13, 2017 · Recall initiated: May 2, 2017

Summary

FDA records drug Class III recall D-1127-2017, published September 13, 2017 and initiated May 2, 2017. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 12,888 bottles; Lot: Lot #: G606950, Exp 07/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · E-Mail

Get an email if FAMOTIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FAMOTIDINE
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide in the USA
UPC
0368180150015
Lot
Lot #: G606950, Exp 07/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine for Oral Suspension USP, 40 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA, NDC 68180-150-01 recalled?

Yes. FDA published recall D-1127-2017 on September 13, 2017. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0368180150015.